Author:
Kim In Sook,Kim Yun,Kwak Tae Hwan,Yoo Hye Hyun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference14 articles.
1. Choi EK, Terai K, Ji I-M, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim J-S, Lee DS, Boothman DA, Loren M, Song CW, Park HJ (2007) Upregulation of NAD(P)H: quinone oxidoreductase by radiation potentiates the effect of bioreductive β-lapachone on cancer cells. Neoplasia 9:634–642
2. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR, Wilding G, Boothman DA (1995) Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res 55:3706–3711
3. Li CJ, Wang C, Pardee AB (1995) Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res 55:3712–3715
4. Weller M, Winter S, Schmidt C, Esser P, Fontana A, Dichgans J, Groscurth P (1997) Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone. Int J Cancer 73:707–714
5. Liu T (2002) Inhibition of poly (ADP-ribose) polymerase activation attenuates β-lapachone-induced necrotic cell death in human osteosarcoma cells. Toxicol Appl Pharmacol 182:116–125
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献